The global embolic protection devices market size was valued at USD 612.9 million in 2023 and is projected to grow at a CAGR of 8.7% from 2024 to 2030. Growing number of patients suffering from cardiovascular and neurovascular disorders is fueling the market growth. The rise in minimally invasive procedures due to the shorter recovery time and less complications compared to traditional surgical methods is driving the market growth.
Embolic protection devices are useful in reducing the complications in procedures such as angioplasty. These devices reduce the chances of debris entering the bloodstream and causing blockages in smaller vessels during cardiac procedures. This is expected to boost the demand for embolic protection devices in the coming years.
Distal filters accounted for the largest share of 49.7% in 2023 due to their ability to offer efficient protection against embolization during interventional procedures. These devices are designed to block the vessel at the end, preventing debris from moving downstream and leading to possible blockages. Moreover, distal occlusion devices provide improved navigability and traceability, allowing accurate placement and removal. The growing demand for less invasive procedures and the rising incidences of cardiovascular diseases are fueling the penetration of distal occlusion devices.
Distal occlusion devices are projected to witness a CAGR of 8.9% over the forecast period. Distal occlusion devices act as a barrier, catching debris such as blood clots, plaque, or other particles that may break loose during interventions, therefore reducing the chance of embolization and related issues.
Cardiovascular diseases dominated the market with a share of 47.8% in 2023 due to the rising prevalence of cardiovascular diseases such as peripheral arterial disease and coronary artery disease. The ongoing research and development efforts to improve the performance of these devices are also leading to segment growth.
Neurovascular diseases are projected to grow at a CAGR of 7.9% over the forecast period. The increasing prevalence of neurovascular disorders such as ischemic aneurysms, stroke, and arteriovenous malformations has led to an increased demand for effective treatment options. Moreover, technological advancements have improved the design and safety of these devices, resulting in increased reliability for patients. The growing awareness among healthcare professionals about the advantages of using embolic protection devices in neurovascular procedures has led to an increase in their usage.
North America embolic protection devices market held 43.9% of the market share in 2023. It is expected to grow rapidly in the coming years due to the high adoption rate of newly developed products, increasing obesity and presence of prominent manufacturers in the region.
The U.S. dominated the North American embolic protection devices market with a share of 77.5% in 2023. It is attributed to the rising incidences of neurovascular and cardiovascular diseases and growing demand for technologically advanced products. According to U.S. Centers for Disease Control and Prevention, every year about 805,00 people suffer from heart attack and coronary heart disease is the most common heart disease that led to the death of 375,476 people in 2021.
Europe embolic protection devices market was identified as a lucrative region in 2023 due to advanced healthcare facilities in the region According to the European Society of Cardiology, cardiovascular diseases are responsible for the majority of deaths in Europe, accounting for almost 45% of all deaths.
The UK embolic protection devices market is expected to grow rapidly in the coming years due to the rising incidences of cardiovascular diseases due to unhealthy dietary practices & lifestyle choices, favorable reimbursement policies and increasing healthcare expenditure in the country.
The Germany embolic protection devices market held a substantial market share in 2023. This is due to the strong healthcare infrastructure and renowned expertise in medical research and development.
Asia Pacific is anticipated to witness significant growth in the coming years owing to the improving healthcare infrastructure, easy access to healthcare services, increasing incidences of cardiovascular diseases, and growing elderly population.
The significant market share of embolic protection devices in China in 2023 can be attributed to the country’s large population base and rising incidences of cardiovascular diseases.
The India embolic protection devices market held a substantial share due to several factors including India’s expanding healthcare infrastructure and growing population.
Some of the key companies in the embolic protection devices market include Boston Scientific Corporation, Edwards Lifesciences Corporation, Abbott, Medtronic and others. Vendors in the market are focusing on increasing their customer base to gain a competitive edge in the industry.
Edwards Lifesciences Corporation specializes in manufacturing and development of devices for structural heart diseases and critical care monitoring.
The following are the leading companies in the embolic protection devices market. These companies collectively hold the largest market share and dictate industry trends.
In April 2024, Emboline, Inc., announced the acquisition of SWAT Medical’s Intellectual Property Portfolio of embolic protection. This acquisition is expected to expand Emboline’s existing portfolio of platform technologies to reduce the risk of stroke caused due to the release of embolic debris in the bloodstream during procedures such as Transcatheter Aortic Valve Replacement (TAVR).
Report Attribute |
Details |
Market size value in 2024 |
USD 658.1 million |
Revenue forecast in 2030 |
USD 1.09 billion |
Growth Rate |
CAGR of 8.7% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Report updated |
August 2024 |
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, application, region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, Australia, Thailand, South Korea, Brazil, Mexico, Colombia, Argentina, South Africa, Saudi Arabia, UAE, Kuwait |
Key companies profiled |
Boston Scientific Corporation ; Edwards Lifesciences Corporation.; Abbott.; Medtronic ; Cardinal Health.; Innovative Cardiovascular Solutions, LLC; Transverse Medical, Inc.; W. L. Gore & Associates, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global embolic protection devices market report based on product, application, and region.
Product Outlook (Revenue, USD Million, 2018 - 2030)
Distal Occlusion Devices
Proximal Occlusion Devices
Distal Filters
Application Outlook (Revenue, USD Million, 2018 - 2030)
Cardiovascular Diseases
Neurovascular Diseases
Peripheral Vascular Diseases
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Mexico
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Thailand
Australia
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."